查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1768802

全球生物净化市场

Bio Decontamination
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 177 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球生物净化市场规模将达到 2.688 亿美元

全球生物净化市场规模预计在2024年为2.06亿美元，到2030年将达到2.688亿美元，2024年至2030年的复合年增长率为4.5%。设备是本报告分析的细分市场之一，预计复合年增长率为4.2%，到分析期结束时将达到1.221亿美元。服务细分市场在分析期间内的复合年增长率预计为5.1%。

美国市场规模估计为 5,620 万美元，中国市场预计复合年增长率为 4.3%

预计2024年，美国生物净化市场规模将达5,620万美元。作为世界第二大经济体，中国市场规模预计到2030年将达到4,230万美元，在2024-2030年的分析期间内，复合年增长率为4.3%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为4.2%和3.5%。在欧洲，预计德国市场的复合年增长率为3.7%。

全球生物净化市场－主要趋势与驱动因素摘要

为什么生物净化在当今世界至关重要？

在当今世界，人们对生物污染风险的认识显着提高，生物净化已成为医疗保健、製药、食品加工和公共场所等各行各业的关键业务。生物净化涉及从表面、空气和设备中去除或灭活有害病原体，例如细菌、病毒、真菌和孢子，以降低感染风险，防止污染，并确保产品和人员的安全。例如，在医疗保健环境中，严格的生物净化对于防止医院内感染 (HAI) 的传播至关重要，这种感染每年影响数百万患者，并构成严重的健康风险。同样，製药公司和实验室中的污染，即使是微量污染，也可能威胁产品品质、研究结果和法规遵从性，凸显了严格净化通讯协定的重要性。 COVID-19 疫情进一步凸显了生物净化的必要性，世界各地的组织都在寻求可靠的方法对高频接触表面进行消毒，以确保员工和客户的安全。随着人们对感染疾病控制和卫生标准认识的不断提高，生物净化已成为许多行业维持安全、卫生和合规环境的必要条件——最终成为我们日益互联的空间中公共健康和安全的基石。

哪些新兴技术正在影响生物净化？

近年来，科技进步彻底改变了生物净化工艺，催生了各种创新方法，使净化过程更快、更有效、更环保。其中最具突破性的创新之一是汽化过氧化氢 (VHP) 净化技术的开发，它透过将过氧化氢蒸气扩散到密闭环境中来杀灭多种病原体。这种方法非常有效，因为它能够穿透难以触及的区域，使复杂的表面和精密的设备能够完全消毒，且不留下有害残留物。紫外线 (UV-C) 光技术也得到了广泛应用，它提供了一种快速、无化学物质的表面和空气净化方法，特别适用于医院、实验室和人流量大的公共区域。随着 UV-C 系统越来越可携式且经济高效，它们正部署到从暖通空调系统到公共交通等各种环境中。机器人和自动化技术进一步增强了这些技术，使其能够实现精准一致的应用，减少对人工的依赖，最大限度地降低出错的可能性，并全面覆盖受污染的空间。臭氧净化和离子化过氧化氢等其他技术因其能够有效净化大面积开放区域和空气处理系统而日益普及。这些技术进步正在将生物净化转变为更快速、更安全、更灵活的过程，帮助各行各业维持严格的卫生标准，并降低病原体传播的风险。

企业在实施生物净化时面临哪些挑战？

儘管生物净化具有明显的优势，但其实施也面临重大挑战，尤其是在业务中断、法规遵循和成本管理方面。许多净化方法，例如气化热处理 (VHP)，需要在净化过程中暂时关闭并密闭设施，以确保最佳的蒸气浓度和有效性。在需要持续运作的环境中，例如医院和製造工厂，这种停机时间尤其具有挑战性。此外，遵守严格的安全和环境法规至关重要。某些净化化学品如果使用和处置不当，可能会对工人的健康构成风险，并对环境造成负面影响。医疗保健、製药和食品加工等行业受到严格监管，FDA、EPA 和 OSHA 等机构监督净化通讯协定和工人安全，因此法规遵循是实施过程中不可或缺的环节。此外，对于规模较小的组织来说，先进的净化技术和程序的成本可能是一个重大障碍，因为在专用设备、员工培训和基础设施调整方面需要大量的初始投资。此外，针对特定环境选择合适的净化方法需要仔细考虑各种因素，例如目标病原体、设施布局以及待处理表面的性质，这又增加了一层复杂性。这些挑战意味着，企业在实施生物净化流程时必须投入策略规划和专家指导，以有效满足业务、安全和监管要求。

推动生物净化市场成长的关键因素有哪些？

生物净化市场正经历强劲成长，这得益于人们日益增强的感染预防意识、不断变化的监管要求以及快速的技术进步，这些技术使净化更加高效便捷。尤其是在医疗保健环境中，对感染控制的重视催生了对旨在最大程度减少医院内感染 (HAI) 和其他感染疾病传播的综合净化解决方案的巨大需求。处理敏感产品和数据的行业，例如製药、生物技术和食品加工，尤其需要成熟的净化方法，以确保合规性并维护产品完整性。此外，VHP、UV-C 紫外线和机器人系统等技术进步使生物净化更快、更安全。这些创新提供了可适应不同环境和营运限制的有效解决方案。包括 COVID-19 疫情在内的感染疾病疫情凸显了公共场所生物净化的重要性，导致交通运输、餐旅服务业、零售和政府机构等行业的需求增加。消费者对卫生和安全意识的提高，使得人们越来越青睐那些重视生物净化的公司，这进一步推动了市场扩张。这些驱动因素共同推动了生物去污市场向前发展，使生物去污在全球各行各业维护卫生、安全和法规遵从的努力中发挥关键作用。

部分

产品与服务（设备、服务、耗材）；最终用户（製药与医疗设备公司、生命科学与生物技术研究机构、医院与医疗机构）

受访公司范例

  • Amira Srl
  • ClorDiSys Solutions, Inc.
  • Ecolab
  • Fedegari Autoclavi SpA
  • Howorth Air Technology Ltd.
  • JCE Biotechnology
  • Noxilizer, Inc.
  • STERIS PLC
  • TOMI Environmental Solutions Inc.
  • Wenzhou Weike Biological Laboratory Equipment Co. Ltd.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP21328

Global Bio Decontamination Market to Reach US$268.8 Million by 2030

The global market for Bio Decontamination estimated at US$206.0 Million in the year 2024, is expected to reach US$268.8 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Equipment, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$122.1 Million by the end of the analysis period. Growth in the Services segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$56.2 Million While China is Forecast to Grow at 4.3% CAGR

The Bio Decontamination market in the U.S. is estimated at US$56.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$42.3 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Bio Decontamination Market - Key Trends and Drivers Summarized

Why Is Bio Decontamination Essential in Today’s World?

In today’s world, bio decontamination has become a critical practice across a wide array of industries, including healthcare, pharmaceuticals, food processing, and public spaces, as the awareness of biological contamination risks has risen significantly. Bio decontamination involves the targeted removal or inactivation of harmful pathogens, such as bacteria, viruses, fungi, and spores, from surfaces, air, and equipment to reduce infection risk, prevent contamination, and ensure the safety of both products and people. In healthcare environments, for instance, rigorous bio decontamination is essential to prevent the spread of hospital-acquired infections (HAIs), which impact millions of patients annually and pose serious health risks. Similarly, in pharmaceutical manufacturing and research laboratories, contamination, even at minute levels, can compromise product quality, research outcomes, and regulatory compliance, underlining the importance of stringent decontamination protocols. The COVID-19 pandemic further highlighted the necessity of bio decontamination, as organizations worldwide sought reliable ways to sanitize high-contact areas to ensure the safety of both employees and customers. In light of the growing recognition of infection control and hygiene standards, bio decontamination has become indispensable in maintaining safe, hygienic, and compliant environments across numerous industries, ultimately serving as a cornerstone for public health and safety in increasingly interconnected spaces.

What Advanced Technologies Are Shaping Bio Decontamination?

Recent advancements in technology have revolutionized bio decontamination, offering a range of innovative methods that make the process faster, more effective, and environmentally friendly. One of the most transformative innovations has been the development of vaporized hydrogen peroxide (VHP) decontamination, which involves dispersing hydrogen peroxide vapor into a sealed environment to eliminate a broad spectrum of pathogens. This method is highly effective, as it can penetrate hard-to-reach areas, ensuring complete sterilization of complex surfaces and sensitive equipment without leaving harmful residues. Ultraviolet-C (UV-C) light technology has also become widely adopted, providing a quick, chemical-free approach to surface and air decontamination that is particularly suited for hospitals, laboratories, and high-traffic public areas. As UV-C systems become more portable and cost-effective, they are being deployed in diverse settings, from HVAC systems to public transport. Robotics and automation have further enhanced these technologies, allowing for precise, consistent application and reducing reliance on human labor, which minimizes the potential for error and ensures comprehensive coverage of contaminated spaces. Additional technologies, such as ozone decontamination and ionized hydrogen peroxide, are gaining traction for their ability to sanitize large, open areas and air handling systems effectively. Together, these technological advances are transforming bio decontamination into a faster, safer, and more adaptable process, enabling various sectors to maintain rigorous hygiene standards and reduce pathogen transmission risks.

What Challenges Do Organizations Face in Implementing Bio Decontamination?

Despite the clear benefits, implementing bio decontamination poses significant challenges, particularly related to operational disruption, regulatory compliance, and cost management. Many decontamination methods, such as VHP, require facilities to be temporarily closed off and airtight during the process to ensure optimal vapor concentration and effectiveness, which can disrupt daily operations and lead to productivity losses. This downtime can be particularly challenging in settings that require continuous operation, such as hospitals or manufacturing plants. Moreover, compliance with stringent safety and environmental regulations is crucial, as certain decontamination chemicals, if not applied and disposed of correctly, can pose health risks to personnel and have adverse environmental impacts. Industries like healthcare, pharmaceuticals, and food processing are highly regulated, with agencies like the FDA, EPA, and OSHA overseeing decontamination protocols and worker safety, making adherence to regulations a non-negotiable aspect of implementation. Additionally, the cost of advanced decontamination technologies and procedures can be a significant barrier for smaller organizations, as initial investments in specialized equipment, staff training, and infrastructure adjustments can be substantial. Choosing the appropriate decontamination method for a given environment adds another layer of complexity, requiring careful consideration of factors such as the pathogens being targeted, facility layout, and the nature of surfaces being treated. These challenges underscore the need for organizations to invest in strategic planning and expert guidance when implementing bio decontamination processes to ensure they meet operational, safety, and regulatory requirements effectively.

What Are the Key Growth Drivers in the Bio Decontamination Market?

The bio decontamination market is experiencing strong growth, fueled by rising awareness of infection prevention, evolving regulatory requirements, and rapid technological advancements that make decontamination more efficient and accessible. The emphasis on infection control, particularly in healthcare settings, has created substantial demand for comprehensive decontamination solutions designed to minimize the spread of HAIs and other infectious diseases. Regulatory agencies worldwide are enforcing stricter hygiene standards, especially for industries handling sensitive products or data, such as pharmaceuticals, biotechnology, and food processing, which are required to adopt proven decontamination methods to ensure compliance and maintain product integrity. Additionally, advancements in technologies such as VHP, UV-C light, and robotic systems are making bio decontamination faster and safer, as these innovations provide effective solutions that can adapt to various environments and operational constraints. The increased prevalence of infectious disease outbreaks, including the COVID-19 pandemic, has also underscored the importance of bio decontamination in public spaces, leading to higher demand from sectors such as transportation, hospitality, retail, and government facilities. As consumers become more aware of hygiene and safety, they are more inclined to support businesses that prioritize bio decontamination, further driving market expansion. Collectively, these drivers are propelling the bio decontamination market forward, solidifying its role as a critical component in global efforts to maintain health, safety, and regulatory compliance across a wide range of industries.

SCOPE OF STUDY:

The report analyzes the Bio Decontamination market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product & Service (Equipment, Services, Consumables); End-Use (Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations, Hospitals & Healthcare Facilities)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Amira S.r.l
  • ClorDiSys Solutions, Inc.
  • Ecolab
  • Fedegari Autoclavi SpA
  • Howorth Air Technology Ltd.
  • JCE Biotechnology
  • Noxilizer, Inc.
  • STERIS PLC
  • TOMI Environmental Solutions Inc.
  • Wenzhou Weike Biological Laboratory Equipment Co. Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Bio Decontamination - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Infection Control Drives Growth in Bio Decontamination Market
    • Increasing Use of Bio Decontamination in Healthcare Expands Demand for Effective Solutions
    • Here's How Advances in Decontamination Technologies Enhance Efficacy Against Pathogens
    • Growing Focus on Patient Safety Supports Adoption of Bio Decontamination in Hospitals
    • Rising Demand for Chemical-Free Decontamination Fuels Use of UV and Vapor-Based Solutions
    • Here's How Automation in Decontamination Systems Reduces Labor Costs and Human Error
    • Focus on Minimizing Cross-Contamination Supports Demand for Routine Decontamination Protocols
    • Advancements in Portable Decontamination Devices Expand Applications Beyond Healthcare
    • Growing Demand for Decontamination Solutions in Pharmaceutical and Biotech Labs
    • Here's How Bio Decontamination Enhances Safety in Food Processing and Manufacturing
    • Rising Adoption of Remote Monitoring and Digital Controls Improves Decontamination Accuracy
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bio Decontamination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bio Decontamination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Bio Decontamination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Pharma & Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Life Sciences & Biotech Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Life Sciences & Biotech Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Life Sciences & Biotech Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Healthcare Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Healthcare Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals & Healthcare Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Bio Decontamination Market Analysis of Annual Sales in US$ for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • JAPAN
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • CHINA
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • EUROPE
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Bio Decontamination by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Bio Decontamination by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Bio Decontamination by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • FRANCE
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • GERMANY
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Rest of Europe 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Europe 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Asia-Pacific 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Asia-Pacific 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of World 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of World 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030

IV. COMPETITION